Corteva (NYSE:CTVA) Shares Unloaded by Rep. Gilbert Ray Cisneros, Jr.

Key Points

• Rep. Gilbert Ray Cisneros Jr. sold between $1,001 and $15,000 of Corteva shares on September 17 from a Bank of America trust account. He also reported several other stock purchases and sales in late September and early October.
• Corteva reported quarterly EPS of $2.30, beating estimates of $2.24, though revenue declined 1.2% year over year to $6.38 billion. The company pays a quarterly dividend of $0.18, equating to a 5.4% annualized yield.
• Analyst sentiment remains generally positive, with a consensus “Moderate Buy” rating and 16 Buy ratings versus six Holds and one Sell. Institutional ownership stands at 81.54%, with Wellington Management increasing its position substantially during the second quarter.

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of Corteva, Inc. (NYSE:CTVA). In a filing disclosed on October 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Corteva stock on September 17th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $15,001 - $50,000 in shares of Benchmark Electronics NYSE: BHE on 10/1/2026.
• Sold $1,001 - $15,000 in shares of Oxford Industries NYSE: OXM on 9/29/2026.
• Sold $1,001 - $15,000 in shares of Semtech NASDAQ: SMTC on 9/29/2026.
• Sold $15,001 - $50,000 in shares of ITT NYSE: ITT on 9/29/2026.
• Sold $1,001 - $15,000 in shares of BridgeBio Pharma NASDAQ: BBIO on 9/29/2026.
• Purchased $1,001 - $15,000 in shares of Tandem Diabetes Care NASDAQ: TNDM on 9/29/2026.
• Purchased $1,001 - $15,000 in shares of Cytokinetics NASDAQ: CYTK on 9/29/2026.
• Purchased $1,001 - $15,000 in shares of Ultragenyx Pharmaceutical NASDAQ: RARE on 9/29/2026.
• Purchased $1,001 - $15,000 in shares of YETI NYSE: YETI on 9/29/2026.
• Sold $1,001 - $15,000 in shares of AtriCure NASDAQ: ATRC on 9/29/2026.

Corteva Price Performance

Corteva stock opened at $13.33 on Wednesday. The firm has a fifty day moving average of $68.92 and a 200-day moving average of $77.33. Corteva, Inc. has a 52-week low of $11.74 and a 52-week high of $90.97. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $8.89 billion, a P/E ratio of 3.51, a PEG ratio of 1.86 and a beta of 0.57.

Corteva (NYSE:CTVA - Get Free Report) last posted its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. During the same quarter in the previous year, the business posted $2.20 EPS. The business's quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, analysts predict that Corteva, Inc. will post 1.04 EPS for the current year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st were given a $0.18 dividend. The ex-dividend date of this dividend was Tuesday, September 1st. This represents a $0.72 annualized dividend and a dividend yield of 5.4%. Corteva's dividend payout ratio is presently 47.68%.

Analysts Set New Price Targets

Several research analysts have commented on the company. Morgan Stanley reissued an "overweight" rating and issued a $18.00 price objective on shares of Corteva in a research report on Friday, October 2nd. Oppenheimer set a $17.00 target price on Corteva in a research report on Monday, October 5th. Weiss Ratings downgraded Corteva from a "hold (c+)" rating to a "hold (c)" rating in a research report on Monday, August 3rd. Mizuho increased their target price on Corteva from $96.00 to $97.00 and gave the company an "outperform" rating in a research note on Tuesday, July 14th. Finally, New Street Research set a $17.00 target price on Corteva in a report on Monday, October 5th. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $60.59.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in CTVA. Wellington Management Group LLP increased its position in Corteva by 941.7% in the 2nd quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company's stock valued at $644,720,000 after acquiring an additional 6,881,875 shares during the period. Rakuten Investment Management Inc. acquired a new position in Corteva during the 2nd quarter worth $9,132,000. Kingsview Wealth Management LLC acquired a new position in Corteva during the 2nd quarter worth $1,093,000. Jupiter Topco LLC bought a new position in shares of Corteva in the second quarter worth $544,246,000. Finally, Bank of New York Mellon Corp bought a new position in shares of Corteva in the second quarter worth $392,447,000. 81.54% of the stock is currently owned by institutional investors.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Corteva Company Profile

Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.

The company's seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.

Corteva serves farmers, agricultural retailers and other customers in markets around the world.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.